neuropathic pain

Showing 5 posts of 5 posts found.

Lundbeck acquire Abide Therapeutics in deal worth $400 million

May 7, 2019
Manufacturing and Production, Sales and Marketing Abide Therapeutics, Lundbeck, endocannabinoid system, neuropathic pain, tourette's

Danish firm Lundbeck has agreed to acquire San Diego-based biotech Abide Therapeutics as part of a deal worth $400 million. …


High Court rules against Pfizer in Lyrica patent case

September 10, 2015
Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin

The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …

Pfizer image

Pfizer offers to pay for UK Lyrica switches

August 13, 2015
Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin

Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …

Pfizer picture

Lyrica fails in diabetes and HIV pain

May 9, 2012
Sales and Marketing Lyrica, Pfizer, neuropathic pain, pain

Two separate Phase III trials of Lyrica have failed to show benefits in treating nerve pain – one in HIV …

Blocking pain – a long-term mission for pharma research

October 5, 2011
Research and Development chronic pain, neuropathic pain, pain therapeutics

Pain is a common, yet complex, clinical problem and one which remains an area of unmet need. There are however, …

Latest content